je.st
news
Home
› Second Circuit Affirms Preliminary Injunction in People of the State of New York v. Actavis PLC
Second Circuit Affirms Preliminary Injunction in People of the State of New York v. Actavis PLC
2015-06-02 23:30:41| Biotech - Topix.net
We've previously covered the New York State Attorney General's lawsuit against Actavis PLC and Forest Laboratories seeking to prevent them from discontinuing sales of the Forest drug Namenda IR, which is used to treat Alzheimer's disease. New York has alleged that Actavis and Forest are engaging in "product hopping" - attempting to force prescribers and patients to switch to a new extended-release version of Namenda before a generic version can be launched.
Tags: v
people
state
york
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||